- Home
- MOGU vs MRNS Comparison
MOGU vs MRNS Comparison
Compare MOGU & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- MRNS
- Stock Information
- Founded
- MOGU 2011
- MRNS 2003
- Country
- MOGU China
- MRNS United States
- Employees
- MOGU N/A
- MRNS N/A
- Industry
- MOGU Business Services
- MRNS Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- MRNS Health Care
- Exchange
- MOGU Nasdaq
- MRNS Nasdaq
- Market Cap
- MOGU 18.7M
- MRNS 15.1M
- IPO Year
- MOGU 2018
- MRNS 2014
- Fundamental
- Price
- MOGU $2.33
- MRNS $0.23
- Analyst Decision
- MOGU
- MRNS Buy
- Analyst Count
- MOGU 0
- MRNS 12
- Target Price
- MOGU N/A
- MRNS $4.28
- AVG Volume (30 Days)
- MOGU 4.5K
- MRNS 1.0M
- Earning Date
- MOGU 01-03-2025
- MRNS 11-12-2024
- Dividend Yield
- MOGU N/A
- MRNS N/A
- EPS Growth
- MOGU N/A
- MRNS N/A
- EPS
- MOGU N/A
- MRNS N/A
- Revenue
- MOGU $19,801,126.00
- MRNS $31,466,000.00
- Revenue This Year
- MOGU N/A
- MRNS $15.71
- Revenue Next Year
- MOGU N/A
- MRNS $40.57
- P/E Ratio
- MOGU N/A
- MRNS N/A
- Revenue Growth
- MOGU N/A
- MRNS 1.63
- 52 Week Low
- MOGU $1.62
- MRNS $0.23
- 52 Week High
- MOGU $3.58
- MRNS $11.26
- Technical
- Relative Strength Index (RSI)
- MOGU 59.92
- MRNS 24.51
- Support Level
- MOGU $2.17
- MRNS $0.23
- Resistance Level
- MOGU $2.49
- MRNS $0.26
- Average True Range (ATR)
- MOGU 0.14
- MRNS 0.02
- MACD
- MOGU 0.03
- MRNS 0.02
- Stochastic Oscillator
- MOGU 91.07
- MRNS 0.00
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.